Skip to main content
ZheJiang Tailin Bioengineering Co.,Ltd logo

ZheJiang Tailin Bioengineering Co.,Ltd — Investor Relations & Filings

Ticker · 300813 ISIN · CNE100003S89 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,000 across all filing types
Latest filing 2020-03-12 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300813

About ZheJiang Tailin Bioengineering Co.,Ltd

https://www.tailingood.com

ZheJiang Tailin Bioengineering Co.,Ltd. specializes in the research, development, and manufacturing of high-tech equipment for life sciences and pharmaceutical engineering. The company provides integrated solutions for microbial control, sterility testing, and aseptic processing. Its core product portfolio includes sterility test canisters and pumps, microbial limit testing systems, and hydrogen peroxide vapor (VHP) decontamination units. Tailin also develops advanced isolator technology for containment and aseptic applications, alongside analytical instruments such as Total Organic Carbon (TOC) analyzers and filter integrity testers. These products are designed to meet international regulatory standards, including GMP, USP, and EP. The company serves sectors such as biopharmaceuticals, medical devices, and laboratory research, focusing on product safety and quality through specialized engineering and microbial detection technologies.

Recent filings

Filing Released Lang Actions
董事会议事规则（2020年3月）
Governance Information Classification · 100% confidence The document is titled '董事会议事规则' which translates to 'Board Meeting Rules' or 'Rules of Procedure for the Board of Directors' of Zhejiang Tailin Biotechnology Co., Ltd. The content extensively details the structure, duties, meeting procedures, decision-making processes, and responsibilities of the board of directors. It includes sections on board composition, meeting notification, voting, conflict of interest, and other governance-related matters. There is no financial data, audit information, or report of financial results. It is a governance document outlining internal rules and practices of the board. Therefore, this document fits the category of Governance Information (CGR). The document length is substantial (9197 characters), indicating it is the full governance rules, not just an announcement or summary.
2020-03-12 Chinese
监事会议事规则（2020年3月）
Governance Information Classification · 95% confidence The document is titled as rules for the Supervisory Board meetings of Zhejiang Tailin Biotechnology Co., Ltd. It details the procedures, meeting types, proposal submission, voting, record keeping, and other governance-related processes for the Supervisory Board. There is no financial data, no mention of financial results, no regulatory filings, no announcements of votes or dividends, no management changes, no legal proceedings, no capital updates, and no investor presentations. The content is focused on internal governance rules and procedures, which aligns with governance information. The document length is 2776 characters, which is relatively short but contains substantive governance content, not just an announcement. Therefore, the best fitting category is Governance Information (CGR).
2020-03-12 Chinese
独立董事关于第二届董事会第八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion regarding the company's board meeting matters, specifically about the use of idle raised funds and own funds for cash management. It references compliance with regulatory guidelines and company rules, and it is signed by independent directors. The content is a formal opinion or statement related to board decisions, not a full financial report, earnings release, or audit report. It is not a report publication announcement or a certification letter but a management or board-related document. Therefore, it fits best under Board/Management Information (MANG), which covers announcements of changes or opinions related to the company's board or senior management activities.
2020-03-12 Chinese
关于变更公司注册资本、公司类型及修改公司章程的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Zhejiang Tailin Biotechnology Co., Ltd. regarding changes to the company's registered capital, company type, and amendments to the company bylaws (articles of association). It references regulatory approvals, board resolutions, and shareholder authorizations related to these corporate changes. The document does not contain financial statements or detailed financial performance data, nor is it a report or presentation. Instead, it is a formal announcement of corporate structural changes and related governance document amendments. This fits the category of Share Issue/Capital Change (SHA), as it involves changes in registered capital and company type due to a public offering and listing.
2020-03-12 Chinese
公司章程（2020年3月）
Governance Information Classification · 95% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Zhejiang Tailin Bioengineering Co., Ltd. It contains detailed chapters on company governance, shareholder rights, board of directors, management, financial accounting, and other corporate governance matters. It references relevant laws and regulations such as the Company Law of China, Securities Law, and Shenzhen Stock Exchange rules. The content is a comprehensive governance document outlining the internal rules and structure of the company rather than a financial report, announcement, or meeting material. This matches the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is substantial and contains detailed governance provisions, not just an announcement or summary. Therefore, the correct classification is CGR with high confidence.
2020-03-12 Chinese
第二届监事会第五次会议决议的公告
Regulatory Filings Classification · 95% confidence The document is an announcement of a supervisory board meeting resolution regarding the use of idle raised funds and own funds for cash management. It includes details about the meeting date, attendance, agenda, voting results, and references to related documents disclosed on a regulatory information website. The document is short (1016 characters) and does not contain financial statements or detailed financial data. It is an official announcement of a board/committee decision rather than a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2020-03-12 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.